Fecal microbiota transplantation in gastrointestinal and extraintestinal disorders

Gianluca Ianiro, Jonathan P Segal, Benjamin H Mullish, Mohammed N Quraishi, Serena Porcari, Ginevra Fabiani, Antonio Gasbarrini, Giovanni Cammarota

Risultato della ricerca: Contributo in rivistaArticolo in rivista


Fecal microbiota transplantation (FMT) is the infusion of feces from a healthy donor into the gut of a recipient to treat a dysbiosis-related disease. FMT has been proven to be a safe and effective treatment for Clostridioides difficile infection, but increasing evidence supports the role of FMT in other gastrointestinal and extraintestinal diseases. The aim of this review is to paint the landscape of current evidence of FMT in different fields of application (including irritable bowel syndrome, inflammatory bowel disease, liver disorders, decolonization of multidrug-resistant bacteria, metabolic disorders and neurological disorders), as well as to discuss the current regulatory scenario of FMT, and hypothesize future directions of FMT.
Lingua originaleEnglish
pagine (da-a)1173-1186
Numero di pagine14
RivistaFuture Microbiology
Stato di pubblicazionePubblicato - 2020


  • Animals
  • Clostridium difficile
  • Fecal Microbiota Transplantation
  • Gastrointestinal Microbiome
  • Humans
  • Intestinal Diseases
  • Metabolic Diseases
  • Nervous System Diseases
  • cancer
  • fecal microbiota transplantation
  • inflammatory bowel disease
  • irritable bowel syndrome
  • metabolic syndrome
  • microbiome
  • microbiota


Entra nei temi di ricerca di 'Fecal microbiota transplantation in gastrointestinal and extraintestinal disorders'. Insieme formano una fingerprint unica.

Cita questo